痛风治疗目标小册子的发展
N Mustafa1, M R Isa1, H Baharuddin2
1Universiti Teknologi MARA Sungai Buloh Campus, Faculty of Medicine, Sungai Buloh, Selangor, Malaysia.
The Medical journal of Malaysia
|January 30, 2024
概括
开发和验证了一本新的痛风治疗目标手册,以帮助患者了解降尿酸治疗的开始和剂量升级,以更好地治疗痛风.
科学领域:
- 类风湿病学 类风湿病学
- 患者教育 患者教育
- 痛风管理 痛风管理
背景情况:
- 痛风管理指南建议采用治疗到点血清尿酸的方法.
- 患者存在关于启动和剂量升级尿酸降低疗法 (ULT) 的困惑.
研究的目的:
- 开发和验证一种痛风治疗目标手册,用于患者教育.
- 改善患者对ULT启动和剂量升级的理解.
主要方法:
- 一本小册子是由三个顾问类风湿病学家组成的团队开发的.
- 内容验证涉及11名医生;面部验证涉及10名痛风患者.
主要成果:
- 项目内容有效性指数 (I-CVI) 在相关性,清晰度,模糊性和简单性方面从0.9到1不等.
- 项目对面有效性指数 (I-FVI) 为1,表明100%的患者同意.
- 根据评价者的反,添加了尿素剂的副作用.
结论:
- 一本痛风治疗目标小册子成功开发和验证.
- 在医生和患者之间观察到I-FVI和I-CVI的高度一致.
- 这本小册子作为一种有效的工具,用于患者在痛风管理中的教育.
相关概念视频
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
167
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
167
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
Peptic Ulcer Disease IV: Management
93
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
93


